Loading...
UK Trademark — IPO
AFESU
Application UK00917852575 · Registered
Quick Facts
| Application Number | UK00917852575 |
| Status | Registered |
| Owner | Eli Lilly and Company |
| Filed | 2018-02-22 |
| Registered | 2018-07-07 |
| Renewal Due | 2028-02-22 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
Yes. AFESU is currently a registered UK trademark, with renewal due on 2028-02-22. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis, prevention and/or treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia; pharmaceutical preparations for the diagnosis, prevention and/or treatment of endocrine diseases and disorders, and gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment, prevention and diagnosis of hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and/or treatment of migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain and Parkinson's disease; pharmaceutical preparations for the diagnosis, prevention and/or treatment of Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, and ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases; pharmaceutical preparations.
Timeline
- Filed: 2018-02-22
- Registered: 2018-07-07
- Renewal due: 2028-02-22
About This Trademark
'AFESU' is a registered trademark on the UK IPO register, owned by Eli Lilly and Company. The application (UK00917852575) was filed on 22 February 2018 and registered on 7 July 2018. The registration is set to expire on 22 February 2028.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by Page, White & Farrer Limited.
Frequently Asked Questions
Who owns UK trademark UK00917852575 ('AFESU')?
UK trademark UK00917852575 for the mark 'AFESU' in Class 5 is recorded on the UK IPO register as owned by Eli Lilly and Company. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00917852575 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00917852575 for the mark 'AFESU' as registered.
Which goods or services does UK trademark UK00917852575 cover?
UK trademark UK00917852575 for the mark 'AFESU' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis, prevention and/or treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases,…
When was UK trademark UK00917852575 filed?
UK trademark UK00917852575 for the mark 'AFESU' was filed at the UK IPO on 22 February 2018 and registered on 7 July 2018.
When does UK trademark UK00917852575 need to be renewed?
UK trademark UK00917852575 for the mark 'AFESU' is currently recorded as valid until 22 February 2028, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00917852575?
Page, White & Farrer Limited is listed as the attorney / representative of record for UK trademark UK00917852575 for the mark 'AFESU' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Cross-Register Filings
Trademarks matching "AFESU" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
US — United States (USPTO)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| AFESUSame applicant | 90800553 | 606 | 2021-06-29 |
| AFESUSame applicant | 87800973 | 606 | 2018-02-16 |
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
United States (USPTO)
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.